Tetsuya Kitayama

QT PRODACT: In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals

Shigeki Toyoshima, Akihiro Kanno, Tetsuya Kitayama et al. · Journal of Pharmacological Sciences · 2005 · 95 citations · Full text

QT PRODACT: In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation

Kentaro Ando, Toshiyasu Hombo, Akihiro Kanno et al. · Journal of Pharmacological Sciences · 2005 · 83 citations · Full text

Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R

Osamu Akizuki, Atsushi INAYOSHI, Tetsuya Kitayama et al. · European Journal of Pharmacology · 2008 · 59 citations

Aldosterone Production, Hyperpolarization (Biology), Medicine +6

The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family

Hiromichi Kosaka, Kazunori Hirayama, Nobuyuki Yoda et al. · European Journal of Pharmacology · 2010 · 36 citations

Molecular Pharmacology, Nuclear Receptor Family, Functional Selectivity +8

QT PRODACT: Sensitivity and Specificity of the Canine Telemetry Assay for Detecting Drug-Induced QT Interval Prolongation

Hiroyasu Miyazaki, Hiroyuki Watanabe, Tetsuya Kitayama et al. · Journal of Pharmacological Sciences · 2005 · 32 citations · Full text